/PNTG
PNTG Stock - The Pennant Group, Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$29.34-0.07%
$0.02 (-0.07%) • Dec 19
80
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.84
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.68
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+34.6%upside
Target: $39.49
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PNTG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$29.05 – $29.63
TARGET (TP)$39.50
STOP LOSS$26.99
RISK/REWARD1:4.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.31
52W High$30.46
52W Low$21.18
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $695.24M | $544.89M | $473.24M | $439.69M | $390.95M |
| Gross Profit | $93.76M | $67.04M | $58.59M | $48.59M | $54.89M |
| Gross Margin | 13.5% | 12.3% | 12.4% | 11.1% | 14.0% |
| Operating Income | $38.12M | $25.17M | $12.74M | $4.70M | $18.92M |
| Net Income | $22.56M | $13.38M | $6.64M | $2.70M | $15.74M |
| Net Margin | 3.2% | 2.5% | 1.4% | 0.6% | 4.0% |
| EPS | $0.72 | $0.45 | $0.23 | $0.08 | $0.56 |
Company Overview
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
5
71%
Hold / Neutral
2
29%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
5 Bullish2 Neutral/Bearish
Price Targets
$25
Average Target
↓ 14.4% Downside
Now
$16
Low
$25
Average
$34
High
Based on 8 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 8th 2025 | William Blair | Initiation | Outperform | - |
| December 2nd 2025 | Truist | Upgrade | Buy | $34 |
| November 18th 2025 | Wells Fargo | Upgrade | Overweight | $31 |
| October 24th 2025 | Jefferies | Initiation | Buy | $30 |
| December 19th 2024 | Wells Fargo | Initiation | Equal Weight | $33 |
| January 5th 2024 | Stephens | Upgrade | Overweight | $18← $14 |
| February 27th 2023 | Stifel | Upgrade | Buy | $16← $15 |
| August 25th 2022 | Oppenheimer | Initiation | Outperform | $22 |
| June 21st 2022 | Stephens | Downgrade | Equal Weight | $17← $23 |
Earnings History & Surprises
PNTGBeat Rate
50%
Last 18 quarters
Avg Surprise
+1.4%
EPS vs Estimate
Beats / Misses
9/4
5 met exactly
Latest EPS
$0.30
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.22vs$0.22
Q2 24
+17.6%
$0.20vs$0.17
Q3 24
+9.1%
$0.24vs$0.22
Q4 24
+13.0%
$0.26vs$0.23
Q1 25
0.0%
$0.24vs$0.24
Q2 25
+22.7%
$0.27vs$0.22
Q3 25
+3.8%
$0.27vs$0.26
Q4 25
+3.4%
$0.30vs$0.29
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.32 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.29 | $0.30 | +3.4% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $0.26 | $0.27 | +3.8% | ✓ BEAT |
Q2 2025 | May 6, 2025 | $0.22 | $0.27 | +22.7% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.24 | $0.24 | 0.0% | = MET |
Q4 2024 | Nov 6, 2024 | $0.23 | $0.26 | +13.0% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $0.22 | $0.24 | +9.1% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $0.17 | $0.20 | +17.6% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $0.22 | $0.22 | 0.0% | = MET |
Q4 2023 | Nov 7, 2023 | $0.19 | $0.20 | +5.3% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $0.16 | $0.18 | +12.5% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.15 | $0.13 | -13.3% | ✗ MISS |
Q1 2023 | Feb 23, 2023 | $0.18 | $0.18 | 0.0% | = MET |
Q4 2022 | Nov 7, 2022 | $0.18 | $0.14 | -22.2% | ✗ MISS |
Q3 2022 | Aug 8, 2022 | $0.14 | $0.14 | 0.0% | = MET |
Q2 2022 | May 9, 2022 | $0.08 | $0.11 | +37.5% | ✓ BEAT |
Q1 2022 | Feb 28, 2022 | $0.15 | $0.07 | -53.3% | ✗ MISS |
Q4 2021 | Nov 8, 2021 | $0.11 | $0.11 | 0.0% | = MET |
Q3 2021 | Aug 9, 2021 | $0.19 | $0.17 | -10.5% | ✗ MISS |
Latest News
William Blair Initiates Coverage On Pennant Gr with Outperform Rating
📈 PositiveBenzinga•Dec 8, 2025, 02:31 PM
Truist Securities Upgrades Pennant Gr to Buy, Raises Price Target to $34
📈 PositiveBenzinga•Dec 2, 2025, 04:08 PM
Wells Fargo Upgrades Pennant Gr to Overweight, Raises Price Target to $31
📈 PositiveBenzinga•Nov 18, 2025, 02:49 PM
RBC Capital Maintains Outperform on Pennant Gr, Raises Price Target to $39
📈 PositiveBenzinga•Nov 17, 2025, 01:10 PM
Pennant Gr Raises FY2025 Adj EPS Guidance from $1.09-$1.15 to $1.14-$1.18 vs $1.11 Est; Raises FY2025 Sales Guidance from $852.800M-$887.600M to $911.400M-$948.600M vs $898.234M Est
📈 PositiveBenzinga•Nov 5, 2025, 09:22 PM
Pennant Gr Q3 Adj. EPS $0.30 Beats $0.28 Estimate, Sales $229.039M Beat $222.101M Estimate
📈 PositiveBenzinga•Nov 5, 2025, 09:21 PM
Reported Earlier, Pennant Acquires 55-Bed Twin Rivers Senior Living In Idaho And 135-Bed Honey Creek Heights In Wisconsin
📈 PositiveBenzinga•Nov 5, 2025, 08:21 AM
Stephens & Co. Reiterates Overweight on Pennant Gr, Maintains $40 Price Target
📈 PositiveBenzinga•Oct 9, 2025, 12:25 PM
Stephens & Co. Reiterates Overweight on Pennant Gr, Maintains $40 Price Target
📈 PositiveBenzinga•Sep 4, 2025, 12:55 PM
Pennant Group Acquires Home Health Agency And Outpatient Therapy Operation In Wyoming; Terms Not Disclosed
📈 PositiveBenzinga•Sep 3, 2025, 08:31 PM
Frequently Asked Questions about PNTG
What is PNTG's current stock price?
The Pennant Group, Inc. (PNTG) is currently trading at $29.34 per share. The stock has moved -0.07% today.
What is the analyst price target for PNTG?
The average analyst price target for PNTG is $39.50, based on 1 analyst.
What sector is The Pennant Group, Inc. in?
The Pennant Group, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is PNTG's market cap?
The Pennant Group, Inc. has a market capitalization of $1.01 billion, making it a small-cap company.
Does PNTG pay dividends?
No, The Pennant Group, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMN
AMN Healthcare Services, Inc.
$16.04
Mkt Cap: $0.6B
BCAX
Bicara Therapeutics Inc. Common Stock
$17.60
Mkt Cap: $1.0B
CRMD
CorMedix Inc.
$12.02
Mkt Cap: $0.9B
EYPT
EyePoint Pharmaceuticals, Inc.
$17.43
Mkt Cap: $1.2B
HSTM
HealthStream, Inc.
$23.94
Mkt Cap: $0.7B
IART
Integra LifeSciences Holdings Corporation
$12.65
Mkt Cap: $1.0B
INNV
InnovAge Holding Corp.
$6.00
Mkt Cap: $0.8B
KURA
Kura Oncology, Inc.
$9.84
Mkt Cap: $0.9B
PROK
ProKidney Corp.
$2.37
Mkt Cap: $0.3B
SNDA
Sonida Senior Living, Inc.
$32.95
Mkt Cap: $0.6B
Explore stocks similar to PNTG for comparison